Stamos Capital Partners’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,780
Closed -$2.74M 141
2024
Q4
$2.74M Sell
31,780
-5,500
-15% -$548K 0.64% 43
2024
Q3
$3.53M Buy
37,280
+11,060
+42% +$982K 0.83% 32
2024
Q2
$2.5M Buy
26,220
+5,960
+29% +$709K 0.53% 53
2024
Q1
$2.67M Buy
20,260
+14,350
+243% +$1.77M 0.61% 41
2023
Q4
$854K Buy
5,910
+580
+11% +$79.6K 0.23% 84
2023
Q3
$906K Buy
5,330
+3,060
+135% +$610K 0.2% 97
2023
Q2
$506K Buy
+2,270
New +$464K 0.12% 99
2022
Q4
Sell
-1,140
Closed -$301K 129
2022
Q3
$301K Buy
+1,140
New +$290K 0.08% 172

Other funds holding ALB

Stamos Capital Partners's ALB Position: Q1 2025 in Review

Stamos Capital Partners sold out of Albemarle (ALB) in Q1 2025, closing a stake of 31,780 shares — an estimated $2.74M sold.

Stamos Capital Partners first reported a position in ALB in Q3 2022 and held it in 8 quarters. The position peaked at $3.53M in Q3 2024. 764 funds tracked by Wall St. Rank hold ALB as of Q1 2025.

  • Stamos Capital Partners reported no remaining Albemarle position as of Q1 2025 after selling out during the quarter.
  • Stamos Capital Partners sold 31,780 Albemarle shares in Q1 2025, an estimated $2.74M.
  • Stamos Capital Partners first reported a position in Albemarle in Q3 2022 and held it in 8 quarters.
  • Stamos Capital Partners's Albemarle position peaked at $3.53M in Q3 2024.
  • 764 funds tracked by Wall St. Rank held Albemarle as of Q1 2025.

Based on Stamos Capital Partners's 13F filing for Q1 2025, filed 14 May 2025.